Gene and Cell Therapy
A section of Biomedicines (ISSN 2227-9059).
Section Information
This section of Biomedicines aims to rapidly publish contributions on all aspects of the latest research results concerning gene and cell therapy. We encourage the submission of manuscripts that provide novel and mechanistic insights and papers that report significant advances on the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Intersections between Neurodegeneration, Cancer and Aging: A Proteomics Perspective (Deadline: 30 September 2024)
- Progress in Protein Therapeutics (Deadline: 30 November 2024)
- Galectin as Disease Biomarker (Deadline: 30 November 2024)
- Advances in CAR-T Cell Therapy (Deadline: 30 November 2024)
- Osteoarthritis: Molecular Pathways and Novel Therapeutic Strategies (Deadline: 20 December 2024)
- DNA Methylation Profiling for the Classification and Diagnosis of Tumors (Deadline: 31 December 2024)
- Vascular Malformation: From Pathophysiology, Clinical Manifestations to Novel Therapeutic Approaches (Deadline: 31 January 2025)
- Emerging Trends in the Study of Inherited Metabolic Disorders (Deadline: 31 January 2025)
- Diagnostic and Therapeutic Challenges of CAR-T Cell Therapy (Deadline: 10 February 2025)
- Omics Approaches on Immune-Mediated Inflammatory Diseases: Towards Novel Biomarkers and Potential Therapeutic Targets Vol. 2 (Deadline: 28 February 2025)
Topical Collection
Following topical collection within this section is currently open for submissions: